Nasopharyngeal carcinoma in Sarawak : a 10-year review and update

Eur Arch Otorhinolaryngol. 2024 Dec;281(12):6493-6498. doi: 10.1007/s00405-024-08955-9. Epub 2024 Sep 6.

Abstract

Aim: Nasopharyngeal carcinoma (NPC) is prevalent in certain regions, particularly Southeast Asia and Southern China. In Malaysia, it is notably frequent among the Bidayuh community. This study presents a comprehensive review of NPC cases diagnosed and treated at Sarawak General Hospital from 2010 to 2020.

Method: A retrospective data collection was conducted using the clinical records of patients who were histopathologically diagnosed with NPC at the Otolaryngology-Head & Neck Clinic and the Radiotherapy & Oncology Clinic at Sarawak General Hospital.

Result: The study comprised a total of 892 patients from 2010 to 2020. Males outnumbered females 3-to-1, with a mean age of 51 years (standard deviation: 13.9). The largest groups of patients were the Iban (34%) and the Bidayuh (21%), followed by the Chinese (19%) and the Malay (15%). The Bidayuh had the highest incidence rate with 81 cases per 100,000. Only 10% of the study population had a family history of NPC. The most common presentation was a neck lump (64.5%). Distant metastasis was discovered in 20% of patients. 82% of the cases were stage 3 or 4 at the time of presentation. The histological types of the 892 cases were mainly undifferentiated carcinoma (73%). Eighty-six patients developed recurrence, with 83% experiencing local recurrence, 10% developing distant metastasis, and 7% developing regional recurrence. Treatment for recurrence included nasopharyngectomy, neck dissection, and chemotherapy.

Conclusion: The study highlights a significant incidence of NPC among the Bidayuh. Emphasis on screening and early detection is crucial for better outcomes, with lifelong follow-up recommended.

Keywords: Cancer; Epistaxis; Nasopharyngeal carcinoma; Nasopharynx; Neck lump.

MeSH terms

  • Adult
  • Aged
  • Female
  • Humans
  • Incidence
  • Malaysia / epidemiology
  • Male
  • Middle Aged
  • Nasopharyngeal Carcinoma* / epidemiology
  • Nasopharyngeal Carcinoma* / pathology
  • Nasopharyngeal Carcinoma* / therapy
  • Nasopharyngeal Neoplasms* / epidemiology
  • Nasopharyngeal Neoplasms* / pathology
  • Nasopharyngeal Neoplasms* / therapy
  • Neoplasm Staging
  • Retrospective Studies